Total Payments
$502,595
2024 Payments
$187,440
Companies
16
Transactions
352
Medicare Patients
785
Medicare Billing
$63,569
Payment Breakdown by Category
Other$423,905 (84.3%)
Travel$45,538 (9.1%)
Consulting$22,265 (4.4%)
Food & Beverage$7,128 (1.4%)
Research$3,730 (0.7%)
Education$29.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $418,455 | 97 | 83.3% |
| Travel and Lodging | $45,538 | 135 | 9.1% |
| Consulting Fee | $22,265 | 9 | 4.4% |
| Food and Beverage | $7,128 | 97 | 1.4% |
| Honoraria | $5,450 | 2 | 1.1% |
| Unspecified | $3,730 | 11 | 0.7% |
| Education | $29.00 | 1 | 0.0% |
Payments by Type
General
$498,865
341 transactions
Research
$3,730
11 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Regeneron Healthcare Solutions, Inc. | $218,142 | 148 | $0 (2024) |
| GENZYME CORPORATION | $211,064 | 101 | $0 (2024) |
| Optinose US, Inc. | $41,248 | 60 | $0 (2024) |
| Greer Laboratories, Inc. | $10,875 | 10 | $0 (2017) |
| GlaxoSmithKline, LLC. | $6,172 | 9 | $0 (2021) |
| Celgene Corporation | $5,000 | 2 | $0 (2020) |
| Genentech, Inc. | $4,056 | 3 | $0 (2019) |
| Regeneron Pharmaceuticals, Inc. | $3,150 | 7 | $0 (2024) |
| ALK-Abello, Inc | $1,398 | 4 | $0 (2019) |
| Astellas Pharma Inc | $750.00 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $187,440 | 103 | Regeneron Healthcare Solutions, Inc. ($113,132) |
| 2023 | $90,016 | 64 | GENZYME CORPORATION ($62,093) |
| 2022 | $81,230 | 50 | GENZYME CORPORATION ($48,335) |
| 2021 | $71,933 | 46 | Regeneron Healthcare Solutions, Inc. ($34,796) |
| 2020 | $29,080 | 30 | OptiNose US, Inc. ($11,776) |
| 2019 | $17,415 | 26 | OptiNose US, Inc. ($8,574) |
| 2018 | $13,726 | 17 | Optinose US, Inc. ($13,646) |
| 2017 | $11,755 | 16 | Greer Laboratories, Inc. ($10,875) |
All Payment Transactions
352 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/20/2024 | AERIN MEDICAL INC. | VIVAER STYLUS (Device), RHINAER STYLUS | Food and Beverage | In-kind items and services | $145.05 | General |
| Category: EAR NOSE & THROAT | ||||||
| 11/14/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $11,725.00 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/14/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $162.48 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/11/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $205.57 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/08/2024 | Regeneron Healthcare Solutions, Inc. | — | Travel and Lodging | In-kind items and services | $460.89 | General |
| 11/08/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $35.95 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/07/2024 | Regeneron Healthcare Solutions, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $11,725.00 | General |
| 11/05/2024 | Regeneron Healthcare Solutions, Inc. | — | Travel and Lodging | In-kind items and services | $478.89 | General |
| 10/31/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,283.00 | General |
| Category: Immunology | ||||||
| 10/31/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $1,029.48 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/31/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $221.20 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/29/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $11,725.00 | General |
| Category: Immunology | ||||||
| 10/29/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Travel and Lodging | In-kind items and services | $924.10 | General |
| Category: Immunology | ||||||
| 10/29/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $131.17 | General |
| Category: Immunology | ||||||
| 10/25/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $489.29 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/24/2024 | Regeneron Healthcare Solutions, Inc. | — | Travel and Lodging | In-kind items and services | $29.99 | General |
| 10/23/2024 | Regeneron Healthcare Solutions, Inc. | — | Travel and Lodging | In-kind items and services | $486.98 | General |
| 10/23/2024 | Regeneron Healthcare Solutions, Inc. | — | Travel and Lodging | In-kind items and services | $353.06 | General |
| 10/23/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $62.14 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/23/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $31.41 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/23/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $30.76 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/18/2024 | Regeneron Healthcare Solutions, Inc. | — | Travel and Lodging | In-kind items and services | $195.47 | General |
| 10/18/2024 | Regeneron Healthcare Solutions, Inc. | — | Food and Beverage | In-kind items and services | $54.53 | General |
| 10/01/2024 | Regeneron Pharmaceuticals, Inc. | DUPIXENT (Biological) | — | In-kind items and services | $1,276.88 | Research |
| Study: DUPIXENT CLINICAL DEVELOPMENT PROGRAM • Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/27/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $500.00 | General |
| Category: Immunology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) | Regeneron Pharmaceuticals, Inc. | $1,836 | 5 |
| DUPIXENT CLINICAL DEVELOPMENT PROGRAM | Regeneron Pharmaceuticals, Inc. | $1,277 | 1 |
| A Randomised PhIII study to assess the effect of 100 mg SC Mepolizumab in the nasal polyp score and symptoms in subjects with bilateral Nasal polyps NP and in current need of NP surgery | GlaxoSmithKline, LLC. | $617.41 | 5 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 165 | 217 | $118,758 | $13,496 |
| 2022 | 6 | 205 | 276 | $148,793 | $16,986 |
| 2021 | 5 | 233 | 309 | $175,782 | $20,520 |
| 2020 | 6 | 182 | 211 | $123,873 | $12,566 |
Total Patients
785
Total Services
1,013
Medicare Billing
$63,569
Procedure Codes
23
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 68 | 88 | $24,176 | $4,431 | 18.3% |
| 31231 | Diagnostic exam of nasal passages using an endoscope | Facility | 2023 | 29 | 55 | $53,955 | $3,001 | 5.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 29 | 31 | $12,573 | $2,536 | 20.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 15 | 18 | $12,352 | $2,073 | 16.8% |
| 31575 | Diagnostic exam of voice box using a flexible endoscope | Facility | 2023 | 12 | 13 | $12,909 | $778.44 | 6.0% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Facility | 2023 | 12 | 12 | $2,793 | $676.80 | 24.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 77 | 111 | $30,110 | $6,009 | 20.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 40 | 45 | $18,864 | $3,573 | 18.9% |
| 31231 | Diagnostic exam of nasal passages using an endoscope | Facility | 2022 | 44 | 67 | $64,770 | $3,341 | 5.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 13 | 18 | $12,132 | $2,197 | 18.1% |
| 31575 | Diagnostic exam of voice box using a flexible endoscope | Facility | 2022 | 17 | 20 | $19,599 | $1,124 | 5.7% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Facility | 2022 | 14 | 15 | $3,318 | $741.24 | 22.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 78 | 116 | $31,179 | $6,434 | 20.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 49 | 53 | $21,990 | $4,390 | 20.0% |
| 31231 | Diagnostic examination of nasal passages using an endoscope | Facility | 2021 | 53 | 79 | $73,543 | $4,117 | 5.6% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 28 | 35 | $24,487 | $4,091 | 16.7% |
| 31575 | Diagnostic examination of voice box using flexible endoscope | Facility | 2021 | 25 | 26 | $24,583 | $1,489 | 6.1% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 30 | 35 | $21,953 | $3,134 | 14.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 64 | 72 | $16,499 | $2,835 | 17.2% |
| 31231 | Diagnostic examination of nasal passages using an endoscope | Facility | 2020 | 30 | 43 | $38,645 | $2,136 | 5.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 29 | 30 | $12,100 | $1,867 | 15.4% |
| 31237 | Biopsy or removal of nasal polyp or tissue using an endoscope | Facility | 2020 | 13 | 14 | $19,133 | $1,794 | 9.4% |
| 31575 | Diagnostic examination of voice box using flexible endoscope | Facility | 2020 | 16 | 17 | $15,543 | $799.32 | 5.1% |
About Jayant Pinto
Jayant Pinto is a Otolaryngology healthcare provider based in Chicago, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/22/2006. The National Provider Identifier (NPI) number assigned to this provider is 1891850624.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jayant Pinto has received a total of $502,595 in payments from pharmaceutical and medical device companies, with $187,440 received in 2024. These payments were reported across 352 transactions from 16 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($418,455).
As a Medicare-enrolled provider, Pinto has provided services to 785 Medicare beneficiaries, totaling 1,013 services with total Medicare billing of $63,569. Data is available for 4 years (2020–2023), covering 23 distinct procedure/service records.
Ad
Practice Information
- Specialty Otolaryngology
- Location Chicago, IL
- Active Since 12/22/2006
- Last Updated 10/24/2022
- Taxonomy Code 207Y00000X
- Entity Type Individual
- NPI Number 1891850624
Products in Payments
- DUPIXENT (Biological) $417,708
- Xhance (Drug) $41,203
- Oralair (Drug) $6,175
- NUCALA (Biological) $6,172
- Xolair (Biological) $4,319
- RPC-4046 (Drug) $2,400
- Odactra (Drug) $1,398
- PROPEL (Device) $156.57
- VIVAER STYLUS (Device) $145.05
- ACCLARENT Balloon Inflation Device (Device) $80.20
- FUSION (Device) $66.78
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Otolaryngology Doctors in Chicago
David Conley, Md, MD
Otolaryngology — Payments: $570,748
Otolaryngology $570,748
Robert Kern, Md, MD
Otolaryngology — Payments: $520,207
Otolaryngology $520,207
Dean Toriumi, M.d, M.D
Otolaryngology — Payments: $119,240
Otolaryngology $119,240
Louis Portugal
Otolaryngology — Payments: $114,918
Otolaryngology $114,918
Phillip Losavio
Otolaryngology — Payments: $52,862
Otolaryngology $52,862
Victoria Lee, Md, MD
Otolaryngology — Payments: $44,117
Otolaryngology $44,117